Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.108 (
TAT
)
2,389
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thrombus formation is recognized pathologically in the affected arteries and is supposed to play a major role in the pathogenesis of
Takayasu's arteritis
; however, hemostatic conditions in this disorder have not been elucidated fully. We determined plasma levels of molecular markers for platelet activity (platelet factor 4; PF4, beta-thromboglobulin; beta TG), thrombotic status (thrombin-antithrombin III complex;
TAT
, fibrinopeptide A; FPA), fibrinolytic status (plasmin-alpha 2-plasmin inhibitor complex; PIC, D-dimer), and endothelial injury (von Willebrand factor antigen; vWF:Ag, thrombomodulin; TM) in 30 patients with
Takayasu's arteritis
and 20 age-matched control subjects. Plasma levels of PF4, beta TG,
TAT
, FPA and D-dimer, but not PIC, in patients with
Takayasu's arteritis
were substantially higher than those in normal control subjects. The levels of these markers were not different between the active and inactive stages of the disease. Plasma levels of vWF:Ag in patients with
Takayasu's arteritis
did not differ significantly from those in normal subjects, and plasma levels of TM were significantly lower than those in normal subjects. In patients with
Takayasu's arteritis
, platelet and coagulation activities are significantly increased, leading to hypercoagulable state and thrombus formation, although there is little, if any, endothelial damage.
...
PMID:Hypercoagulable state in patients with Takayasu's arteritis. 872 10